PRP vs GFC vs Mesotherapy for Hair Loss — Which One Should You Actually Get

1. The Question Every Hair Loss Patient Is Asking Right Now
2. What Is PRP — How It Works and Who It Is Best For
3. What Is GFC — How It Differs From PRP and Why It Is Now Preferred
4. What Is Mesotherapy — Its Role and When It Is the Right Choice
5. The Honest Comparison — Which Is Better in 2026?
6. Sessions, Timeline and What Results to Expect

1 The Question Every Hair Loss Patient Is Asking Right Now

"I have been researching PRP, GFC, and Mesotherapy. I cannot figure out which one I should get." This is now one of the most common questions at Lavanayam Clinic's hair consultations — and it reflects how rapidly the hair treatment landscape has evolved in India over the past three years. Three years ago, PRP was the gold standard and most patients had not heard of GFC. Today, GFC has become the most searched hair treatment in India, Mesotherapy is widely offered as an adjunct, and patients arrive having read contradictory information about all three. The confusion is understandable — the marketing language around these treatments often makes them sound interchangeable when they are not. They work through different mechanisms, are best suited to different types of hair loss, and produce meaningfully different results. Understanding the distinction is what allows the right choice to be made — not for the average patient, but for you specifically.

2 What Is PRP — How It Works and Who It Is Best For

PRP (Platelet-Rich Plasma) is the established, evidence-based baseline treatment in hair restoration injectable therapy. A small sample of the patient's own blood is drawn and centrifuged — a process that separates the blood into its component layers. The platelet-rich plasma layer — which contains growth factors including PDGF (platelet-derived growth factor), VEGF (vascular endothelial growth factor), and EGF (epidermal growth factor) — is collected and injected directly into the scalp at the follicular level. The growth factors delivered by PRP stimulate dormant hair follicles, improve blood supply to the follicular microenvironment, and support the anagen (active growth) phase of the hair cycle. A 2020 systematic review on PubMed analysing 12 PRP trials in androgenetic alopecia found that 84% reported positive treatment outcomes — making PRP one of the most clinically validated non-surgical hair treatments available. PRP is best suited for: Mild to moderate androgenetic alopecia (genetic pattern hair loss) in both men and women — particularly in the early stages where follicles are miniaturising but not yet permanently inactive. Diffuse hair thinning in women, including early female pattern hair loss. Patients who want a well-established, extensively researched treatment with a strong clinical evidence base. Standard PRP requires 4–6 sessions spaced 4–6 weeks apart for the initial course, followed by maintenance every 4–6 months.

3 What Is GFC — How It Differs From PRP and Why It Is Now Preferred

GFC (Growth Factor Concentrate) is an advanced, next-generation evolution of PRP developed in India in 2019–2020 and now widely adopted in dermatology clinics across the country. It addresses the primary limitations of standard PRP through a more refined processing method. In standard PRP, the centrifuged product contains growth factors alongside platelets, red blood cells, white blood cells, and inflammatory proteins. These additional components — particularly the white blood cells and inflammatory mediators — can cause pain during injection and create a local inflammatory response that partially counteracts the growth stimulation. GFC processing goes further: it uses a specialised kit to extract and concentrate only the growth factors — PDGF, VEGF, EGF, and IGF-1 — while removing all cellular components including red and white blood cells. The result is a cell-free, highly concentrated growth factor solution that delivers 5–10 times the growth factor concentration of standard PRP, with significantly less inflammation, less injection discomfort, and faster visible results. Clinical comparisons between GFC and PRP in Indian dermatology practices consistently show that GFC produces comparable or better hair density improvement in fewer sessions. A 2026 comparison published across multiple Indian dermatology clinics indicated that GFC achieves in 3–4 sessions what standard PRP typically requires 5–6 sessions to produce. GFC is best suited for: Moderate to moderately-advanced androgenetic alopecia where faster, more potent follicle stimulation is needed. Patients with significant hair density loss who want visible improvement in fewer clinic visits. Women with PCOS-related hair thinning where a more concentrated growth factor stimulus is appropriate. Patients who found PRP produced partial results and want a more potent alternative. GFC typically requires 4–6 sessions spaced 4–6 weeks apart, with many patients seeing meaningful density improvement as early as session 2–3. Maintenance is every 4–6 months.

4 What Is Mesotherapy — Its Role and When It Is the Right Choice

Mesotherapy is a fundamentally different type of injectable scalp treatment. Unlike PRP and GFC — which use growth factors derived from the patient's own blood — Mesotherapy delivers a customised cocktail of vitamins, minerals, amino acids, DHT blockers, and scalp-nourishing agents directly into the mesoderm (middle layer) of the scalp through microinjections. Mesotherapy does not stimulate follicles with growth factors. Instead, it corrects the nutritional and biochemical environment of the scalp — addressing deficiencies in the follicular microenvironment that impair hair growth even when follicles are structurally intact. It also delivers DHT-blocking agents (such as dutasteride or finasteride in the mesotherapy solution) directly to the follicle, bypassing the systemic side effects that sometimes occur with oral DHT blockers. Mesotherapy is best suited for: Hair loss driven by nutritional deficiencies — iron deficiency, Vitamin D deficiency, zinc deficiency — where the follicles need nourishment rather than growth factor stimulation. Telogen effluvium triggered by stress, illness, postpartum hormonal change, or rapid weight loss — where the hair cycle has been disrupted rather than the follicles structurally miniaturised. Early-stage diffuse thinning where follicles are intact but undernourished. As a complement to GFC or PRP in patients with mixed causes — for example, PCOS-related hair loss where both hormonal DHT suppression (mesotherapy) and growth factor stimulation (GFC) are appropriate simultaneously. Mesotherapy typically requires 6–10 sessions spaced 2–3 weeks apart for the initial course, reflecting its nutritional supplementation mechanism — which requires more frequent dosing than growth factor stimulation.

5 The Honest Comparison — Which Is Better in 2026?

This is the question patients most want answered directly — and it deserves an honest, specific answer rather than the diplomatic "it depends on your condition" non-answer that many clinics give. For moderate-to-significant androgenetic alopecia (genetic pattern hair loss) in men or women: GFC is currently the preferred clinical choice. It delivers more concentrated growth factor stimulation in fewer sessions, with less discomfort and faster visible results than standard PRP. For this indication in 2026, GFC has largely superseded PRP as the first-line injectable treatment at experienced dermatology clinics. For diffuse hair loss driven primarily by nutritional deficiency, stress, or postpartum change: Mesotherapy is the more appropriate starting point. Adding GFC or PRP on top of nutritional deficiency without correcting the deficiency first produces partial results — the follicles cannot respond optimally to growth factor stimulation in a nutrient-depleted environment. For early-stage hair thinning with mixed causes (nutrition + genetics): A sequential protocol — Mesotherapy first to correct the nutritional environment, followed by GFC to stimulate density — consistently produces the best outcomes. This is the protocol Dr. Garima Bhardwaj frequently recommends at Lavanayam for women presenting with PCOS-related hair loss or postpartum thinning, where both nutritional and androgenetic components are present. For patients who want the most established evidence base: PRP remains a well-validated, clinically proven option. GFC has strong emerging evidence but fewer years of long-term outcome data than PRP. For patients who value decades of published research, PRP is still a legitimate choice — particularly in early-stage loss. The most important point: the correct treatment is the one matched to your specific hair loss cause, pattern, and severity — not the one with the most compelling marketing. A trichoscopy-based assessment and blood investigations at consultation are what make this determination accurately.

6 Sessions, Timeline and What Results to Expect

Understanding the realistic timeline for each treatment helps patients commit to the full course rather than abandoning treatment prematurely — which is the most common reason for unsatisfactory results. PRP: 4–6 sessions, 4–6 weeks apart. Results noticeable from session 3–4. Maintenance every 4–6 months. Reduction in shedding is usually the first improvement patients notice, followed by progressive improvement in hair density. GFC: 4–6 sessions, 4–6 weeks apart. Results often noticeable from session 2–3 due to higher growth factor concentration. Maintenance every 4–6 months. Patients with moderate thinning frequently report visible density improvement and reduced scalp visibility by session 3. Mesotherapy: 6–10 sessions, 2–3 weeks apart for initial course. Results develop more gradually — patients typically notice reduced shedding within the first month, with hair thickness improving progressively over 3–4 months. Maintenance every 4–6 weeks for ongoing supplementation. None of these treatments is permanent. They manage hair loss and maintain density while ongoing treatment continues. For patients with significant androgenetic alopecia where follicles have permanently miniaturised, FUE hair transplant is the definitive solution — injectable treatments cannot regrow hair in areas where follicles are permanently lost. For patients near Gaur City 1, Gaur City 2, and Greater Noida West, Dr. Garima Bhardwaj at Lavanayam Clinic offers trichoscopy-guided hair assessment before recommending any injectable treatment — ensuring the choice is based on what your scalp actually shows, not a generalised protocol.